Significant Prognostic Features and Patterns of Somatic TP53 Mutations in Human Cancers

about

Racial disparities in patient survival and tumor mutation burden, and the association between tumor mutation burden and cancer incidence rate.Outcome analysis of Phase I trial patients with metastatic and/or mutant non-small cell lung cancer

P2860

Q42653370-08DFEB4A-F495-4905-AC07-DDA7E00236D3 Q57117154-0D5718EB-A6A6-43E5-8F8E-78CCE13D295F

P2860

Significant Prognostic Features and Patterns of Somatic TP53 Mutations in Human Cancers

Item

http://www.wikidata.org/entity/Q33565858

description

2017 nî lūn-bûn

@nan

2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Significant Prognostic Features and Patterns of Somatic TP53 Mutations in Human Cancers

@ast

Significant Prognostic Features and Patterns of Somatic TP53 Mutations in Human Cancers

@en

Significant Prognostic Features and Patterns of Somatic TP53 Mutations in Human Cancers.

@nl

type

Item

label

Significant Prognostic Features and Patterns of Somatic TP53 Mutations in Human Cancers

@ast

Significant Prognostic Features and Patterns of Somatic TP53 Mutations in Human Cancers

@en

Significant Prognostic Features and Patterns of Somatic TP53 Mutations in Human Cancers.

@nl

prefLabel

Significant Prognostic Features and Patterns of Somatic TP53 Mutations in Human Cancers

@ast

Significant Prognostic Features and Patterns of Somatic TP53 Mutations in Human Cancers

@en

Significant Prognostic Features and Patterns of Somatic TP53 Mutations in Human Cancers.

@nl

P1476

Significant Prognostic Features and Patterns of Somatic TP53 Mutations in Human Cancers

@en

P2093

Andrea Edwards

http://www.w3.org/2001/XMLSchema#string

Kun Zhang

http://www.w3.org/2001/XMLSchema#string

Wensheng Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of the PI3K/Akt/mTOR signaling pathway in diffuse large B-cell lymphoma: current knowledge and clinical significance

How many molecular subtypes? Implications of the unique tumor principle in personalized medicine

Tumor suppressor p53 and its gain-of-function mutants in cancer

Mutational landscape and significance across 12 major cancer types

Toward an evolutionary model of cancer: Considering the mechanisms that govern the fate of somatic mutations

Detection of nonneutral substitution rates on mammalian phylogenies

Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer.

The proline-rich region of mouse p53 influences transactivation and apoptosis but is largely dispensable for these functions.

Nondisruptive p53 mutations are associated with shorter survival in patients with advanced non-small cell lung cancer.

TP53 mutations and survival in squamous-cell carcinoma of the head and neck.

P304

1176935117691267

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1176935117691267

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Erik K Flemington

P577

2017-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28469388

http://www.w3.org/2001/XMLSchema#string

P932

5392013

http://www.w3.org/2001/XMLSchema#string

Significant Prognostic Features and Patterns of Somatic TP53 Mutations in Human Cancers

about

P2860

P2860

Significant Prognostic Features and Patterns of Somatic TP53 Mutations in Human Cancers

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932